|
NUVB
|
Nuvation Bio Inc.
|
US
|
NYSE
|
|
NVAX
|
Novavax, Inc.
|
US
|
NASDAQ
|
|
NVCT
|
Nuvectis Pharma, Inc.
|
US
|
NASDAQ
|
|
NVO
|
Novo Nordisk A/S
|
US
|
NYSE
|
|
NXTC
|
NextCure, Inc.
|
US
|
NASDAQ
|
|
NYMX
|
Nymox Pharmaceutical Corporation
|
US
|
NASDAQ
|
|
OBSV
|
ObsEva SA
|
US
|
NASDAQ
|
|
OLMA
|
Olema Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
OMER
|
Omeros Corporation
|
US
|
NASDAQ
|
|
ONCT
|
Oncternal Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ONCY
|
Oncolytics Biotech Inc.
|
US
|
NASDAQ
|
|
ONTX
|
Onconova Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ORIC
|
Oric Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
ORTX
|
Orchard Therapeutics plc
|
US
|
NASDAQ
|
|
OTLK
|
Outlook Therapeutics, Inc.
|
US
|
NASDAQ
|
|
OVID
|
Ovid Therapeutics Inc.
|
US
|
NASDAQ
|
|
PBLA
|
Panbela Therapeutics, Inc.
|
US
|
NASDAQ
|
|
PCVX
|
Vaxcyte, Inc.
|
US
|
NASDAQ
|
|
PFE
|
Pfizer, Inc.
|
US
|
NYSE
|
|
PHAS
|
PhaseBio Pharmaceuticals, Inc.
|
US
|
NASDAQ
|